Found 10 matching trials
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
PHASE4This research will determine if oral progesterone attenuates drug-induced Q...
Location
Indiana University
Ibutilide Administration During Pulmonary Vein Ablation
NATo test the hypothesis that localized functional reentry maintains Afib in ...
Location
Medical Consultants, P.C.
Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
NAAtrial fibrillation (AF) is one of the most common arrhythmias in clinical ...
Location
National Cardiovascular Diseases Center, Fuwai Hospital
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
PHASE4This research will determine if: 1) Oral progesterone attenuates drug-induc...
Location
Indiana Clinical Research Center
ECGI in Patients With Persistent Atrial Fibrillation
N/ATo determine the values and limitations of ECGI in guiding ablation and ris...
Location
Bumrungrad International Hospital
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
PHASE4Torsades de pointes (TdP) is a potentially fatal ventricular arrhythmia ass...
Location
Indiana University
Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation
NAProcedures for ablation of persistent or long lasting atrial fibrillation a...
Location
Regional Cardiology Associates
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
NAThis is a prospective, multi-center, non-randomized, un-blinded, observatio...
Location
Icahn School of Medicine at Mount Sinai
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
PHASE2Female sex is an independent risk factor for the potentially fatal drug-ind...
Location
Indiana Clinical Research Center
Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation
PHASE4Atrial fibrillation is the most common cardiac arrhythmia and is expected t...
Location
Medical University of Vienna, Department of Emergency Medicine